Arrowhead Pharmaceuticals Inc (ARWR) — Cash Flow Quality Index
Arrowhead Pharmaceuticals Inc (ARWR) has a Cash Flow Quality Index of 1.25x as of March 2025. Operating cash flow of $460.05 Million exceeds net income of $367.86 Million, indicating high earnings quality where cash backs reported profits. Explore how much of Arrowhead Pharmaceuticals Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arrowhead Pharmaceuticals Inc Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Arrowhead Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Arrowhead Pharmaceuticals Inc (ARWR) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Arrowhead Pharmaceuticals Inc (1999–2025)
Year-by-year earnings quality comparison for Arrowhead Pharmaceuticals Inc. For live market cap and the full company financial profile, see ARWR company net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.96x | $179.55 Million | $30.11 Million | ▲ +134.2% |
| 2019 | 2.55x | $173.03 Million | $67.97 Million | ▲ +100.0% |
| 2012 | -191754.63x | $-15.34 Million | $80.00 | ▼ -322877598.6% |
| 1999 | -0.06x | $-35.22K | $593.00K | — |